Jennifer Stevens
Optometrist · Huntington, WVNPI 1457663395
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $29.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$2K
- Alcon$1K
- Coopervision Inc.$1K
- Sun Pharmaceutical Industries Inc.$916
- Bausch & Lomb, A Division Of Bausch Health US, LLC$644
- Johnson & Johnson Vision Care, Inc.$540
- plus $2K from 13 others
What the payments were for
- Food & beverage$7,611100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 61 | $1,786 |
| Alcon | 31 | $1,087 |
| Coopervision Inc. | 35 | $1,058 |
| Sun Pharmaceutical Industries Inc. | 43 | $916 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 18 | $644 |
| Johnson & Johnson Vision Care, Inc. | 14 | $540 |
| AbbVie(2 entities) | 17 | $359 |
| Tarsus Pharmaceuticals, Inc. | 10 | $241 |
| Topcon Healthcare, Inc. | 1 | $182 |
| Novartis | 9 | $181 |
| Oyster Point Pharma, Inc. | 6 | $137 |
| Biotissue Holdings Inc. | 3 | $128 |
| LKC Technologies, Inc. | 2 | $126 |
| Dompe US, Inc. | 3 | $66 |
| Kala Pharmaceuticals, Inc. | 3 | $56 |
| Optovue, Inc. | 1 | $39 |
| Eyevance Pharmaceuticals LLC | 2 | $27 |
| Shire North American Group Inc | 1 | $19 |
| Thea Pharma Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$601
- MyDay Contact Lens$232
- Acuvue$226
- MARLO$142
- TOTAL30$132
- CEQUA$122
- DAILIES$117
- Prokera$107
- AmnioGraft$107
- AmnioGuard$107
How this compares
$7,611 in reported general payments places this provider in the 90th percentile of 210 optometrist providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 61 | $79,362 |
| MieboPerfluorohexyloctane/Pf | 37 | $29,350 |
| CombiganBrimonidine Tartrate/Timolol | 22 | $11,275 |
| LumiganBimatoprost | 12 | $4,958 |
| Brimonidine Tartrate | 41 | $3,509 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 11 | $3,255 |
| Prednisolone Acetate | 84 | $2,173 |
| Latanoprost | 156 | $1,731 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $992 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 56 | $647 |
| Dorzolamide Hcl | 30 | $618 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 12 | $570 |
| Levobunolol Hcl | 17 | $475 |
| Timolol Maleate | 23 | $275 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $269 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Combigan, Lumigan | $359 | $95,59595 claims |
| Bausch & Lomb Americas Inc.Miebo | $1,786 | $29,35037 claims |
| AlconSimbrinza | $1,087 | $3,25511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 210 optometrist providers in West Virginia.
Other optometrist in Huntington
- William RatcliffHuntington$5K
- Chris RatcliffHuntington$5K
- Alvin GinierHuntington$4K
- Gregory MooreBuckhannon$28K
- Steven PotwinSaint Albans$24K
- Kayla CampbellBarboursville$16K
- Lee MooreCharles Town$10K
- Jill ShowalterVienna$10K
- Bryce PeekBarboursville$8K
- James FickClarksburg$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.